Archives for May 2008
Abnormalities Found In Gene For Melanoma
New research from the Oregon Health & Science University Cancer Institute about mutations in melanoma may bring a wellspring of hope to many patients.Researchers have discovered that there are several different kinds of DNA abnormalities that can occur in a gene called the KIT gene. These abnormalities are associated with different kinds of acral and [...]
Rapid Wound Healing
In Germany alone, about three million - mostly elderly - patients suffer from poorly healing large-area wounds caused by complaints such as diabetes, burns or bedsores. The wounds can be treated with conventional collagen dressings or polylactic acid dressings, but the success rate is not as good as it should be. A new type of [...]
Researchers Take Hard Line Against UV Exposure - Hundreds Affirm Harmful Effects Of Ultraviolet Rays, Discourage Intentional Tanning
Researchers have expressed concern over a new campaign initiated by the tanning industry, which seeks to dispel the link between melanoma, the most serious form of skin cancer, and UV exposure from natural or artificial sources (such as tanning beds). In response, nearly 500 of the foremost experts on melanoma signed a statement affirming [...]
Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial For Atopic Dermatitis
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT) has begun Phase 2 clinical testing of PH-10, the company’s topical drug for dermatology, for the treatment of atopic dermatitis, a chronic skin condition that includes some forms of eczema. The study is designed to evaluate efficacy of PH-10 in a total of twenty subjects with mild to severe [...]
Why Some Treatments Rescue Aging Skin
Fine wrinkles, deeper creases, saggy areas around the mouth and neck the sights in the mirror that make baby boomers wince are not inevitable. They result from a structural breakdown inside the skin that some existing treatments effectively counteract by stimulating the growth of new, youthful collagen, University of Michigan scientists say.
Original post by Dermatology [...]
Some Top Brand Sunscreens Don’t Protect Says UK Consumer Watchdog
UK consumer watchdog Which? published research today that shows some top brand sunscreens don’t offer the level of protection they claim on the label.Which? tested 14 brands that claimed to have a sun protection factor (SPF) of 15 and three of them failed the test twice. To pass the test the sunscreens had to produce [...]
Efalizumab (Raptiva) Is Safe For Long-Term Use In Psoriasis Patients
A review of data based on ten years of experience using efalizumab (Raptiva®) to treat chronic plaque psoriasis confirms that that the drug has a favorable long-term safety profile. The chronic plaque form of psoriasis accounts for about 75 percent of psoriasis cases.
Original post by Dermatology News From Medical News Today
Efalizumab Is Safe For Long-Term Use In Psoriasis Patients
A review of data based on ten years of experience using efalizumab (Raptiva®) to treat chronic plaque psoriasis confirms that that the drug has a favorable long-term safety profile. The chronic plaque form of psoriasis accounts for about 75 percent of psoriasis cases.
Original post by Dermatology News From Medical News Today
Arpida Enrols First Patients In “Intravenous-to-Oral” Switch Trial With Oral Iclaprim
Arpida Ltd (SWX: ARPN) announced the enrolment of the first patients into the Phase II “intravenous-to-oral” switch trial with oral iclaprim in complicated Skin and Skin Structure Infections (cSSSI). Enrolment remains on track for completion in 2008. The key objective of the study is to assess the clinical efficacy of an [...]
FDA Clears Of Its Spectra VRM III Q-Switched Nd:Yag Laser System For Treating A Broad Spectrum Of Dermatological And Aesthetic Conditions
Lutronic has announced that it has received FDA clearance to market its Spectra VRM III. This dual pulse Q-Switched Nd:Yag laser is the feature-rich successor to the Spectra VRM II. The laser produces 4 wavelengths (1064 nm, 532 nm, 585 nm, 650 nm) in Q-switched nanosecond [...]